• Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Skip to content
Cannabiz

Cannabiz

The Business of Cannabis

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Home » Archives for Steve Jones » Page 75

Author Archives: Steve Jones

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades.

He is a regulator contributor to health journal, The Medical Republic, writing on issues including the National Disability Insurance Scheme, aged care, mental health and gene editing technology.

He has also held senior editorial roles at publications covering the travel, media and marketing industries.

Vape carts and pastilles on the rise but flower to remain dominant format

by Steve Jones March 14, 2024July 16, 2024

The product mix in Australia will keep evolving with vape carts and pastilles set to rise […]

TGA chides industry for ‘high level’ of advertising non-compliance

by Steve Jones March 14, 2024March 14, 2024

Montu admits ‘level of risk’ with NRL deal but insists pushing boundaries will ‘normalise the conversation’

by Steve Jones March 14, 2024March 14, 2024

‘Dramatic’ AHPRA data reveals level of repeat complaints against medical cannabis prescribers

by Steve Jones March 13, 2024March 13, 2024

Former Cann Group executive Shane Duncan to plot acquisition strategy for Biortica Agrimed

by Steve Jones March 13, 2024March 13, 2024

Montu bids to ‘dispel myths’ as senior exec rejects claims of unethical practices

by Steve Jones March 13, 2024March 13, 2024

Launch of consumer strategy ‘not taken lightly’, as ECS Botanics looks to capitalise on ‘unique IP’

by Steve Jones March 11, 2024March 11, 2024

Alternaleaf brand to appear on NRL players’ jerseys in major sponsorship deal

by Steve Jones March 7, 2024November 25, 2024

Optimism turns to concern as Cann Group battles financial uncertainty

by Steve Jones March 7, 2024March 7, 2024

Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth

by Steve Jones March 7, 2024March 7, 2024

Posts pagination

Newer posts 1 … 73 74 75 76 77 … 145 Older posts

My Account

Sign in

Category

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards

About

  • About/contact us
  • Join
  • Sign in
  • Privacy Policy
  • Website Terms & Conditions
  • Membership Terms & Conditions
  • Submit a Guest Post
  • About cannabis
  • Editorial policy
Cannabiz
  • Linkedin
  • Instagram
© 2026 Cannabiz.